The Institute for Artificial Intelligence in Medicine (I.AIM) has established the Center for Collaborative AI in Healthcare, with the mission of advancing artificial intelligence science, engineering and translation throughout healthcare specialties and create a positive impact on precision medicine.
Twelve faculty with appointments at Feinberg were named to the 2022 “Highly Cited Researchers” list, published by Clarivate Analytics.
Genetic testing in epilepsy patients can inform treatment and lead to better outcomes in many cases, according to a study published in JAMA Neurology.
At Feinberg, scientists are pursuing synthetic biology research to address the health challenges and diseases that humans face.
Northwestern Medicine investigators continue to study the impact of the COVID-19 pandemic on health outcomes and society, from maternal vaccinations and antibody response to reducing burnout amongst healthcare workers and identifying novel therapeutic targets.
A new study has shown that vitamin D supplements do not reduce muscle pain associated with statin drugs.
The Institute for Public Health and Medicine’s Center for Dissemination and Implementation Science recently held its inaugural strategic planning meeting, which welcomed Feinberg faculty to learn about the center’s vision, goals and opportunities for collaboration.
A study led by Northwestern Medicine investigators found that education and place of birth significantly contribute to racial and ethnic differences in cardiovascular health among U.S. adults.
Ann Kennedy, PhD, assistant professor of Neuroscience, has been named the winner of the 2022 Eppendorf and Science Prize for Neurobiology.
Northwestern Medicine scientists have discovered the pathways through which autoantibodies leak out of blood vessels, causing primary graft dysfunction in some lung transplant recipients.
